A phase I trial of paclitaxel, cisplatin, and veliparib in the treatment of persistent or recurrent carcinoma of the cervix: an NRG Oncology Study (NCT#01281852)
Article
Thaker, PH, Salani, R, Brady, WE et al. (2017). A phase I trial of paclitaxel, cisplatin, and veliparib in the treatment of persistent or recurrent carcinoma of the cervix: an NRG Oncology Study (NCT#01281852)
. 28(3), 505-511. 10.1093/annonc/mdw635
Thaker, PH, Salani, R, Brady, WE et al. (2017). A phase I trial of paclitaxel, cisplatin, and veliparib in the treatment of persistent or recurrent carcinoma of the cervix: an NRG Oncology Study (NCT#01281852)
. 28(3), 505-511. 10.1093/annonc/mdw635